Interestingly, developmental tumor cell lines such as teratocarcinomas and neuroblastomas as well as some differentiated glioblastomas, carcinomas and melanomas cell lines often display an MHC class II negative phenotype, even after treatment with IFN-gamma. Here, IFNG is linked to glioblastoma.